Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial

Latest articles

spot_imgspot_imgspot_imgspot_img

Related articles

spot_imgspot_imgspot_imgspot_img